An SEC filing by Allergan (NYSE: AGN) shows takeover talks with a third party believed to be Actavis Plc (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Hot M&A Management Comments Mergers and Acquisitions

Actavis (ACT) Price Target Raised to $280 at Goldman SachsNovember 6, 2014 9:55 AM Valeant Pharma (VRX) on Watch on Actavis/Allergan HeadlinesNovember 6, 2014 9:21 AM Actavis Plc (ACT) said to be in active takeover talks with Allergan (AGN) - BloombergNovember 6, 2014 9:19 AM